UY31836A - Nuevo ácido l-glurámico marcado con [f-18] y derivados de l-glutamina marcada con [f-18] (ii), su uso y procedimientos para su preparación - Google Patents

Nuevo ácido l-glurámico marcado con [f-18] y derivados de l-glutamina marcada con [f-18] (ii), su uso y procedimientos para su preparación

Info

Publication number
UY31836A
UY31836A UY0001031836A UY31836A UY31836A UY 31836 A UY31836 A UY 31836A UY 0001031836 A UY0001031836 A UY 0001031836A UY 31836 A UY31836 A UY 31836A UY 31836 A UY31836 A UY 31836A
Authority
UY
Uruguay
Prior art keywords
marked
derivatives
gluramic
glutamine
procedures
Prior art date
Application number
UY0001031836A
Other languages
English (en)
Inventor
Dr Dinkelborg Ludger
Dr Graham Keith
Dr Berndt Mathias
Dr Koglin Norman
Dr Schmitt-Willich Heribert
Dr Friebe Matthias
Dr Lehmann Lutz
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of UY31836A publication Critical patent/UY31836A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Compuestos y síntesis de ácido L-glutámico marcado [F-18], L-glutamato marcado [F-18], sus derivados de acuerdo con la fórmula (I) y su uso.
UY0001031836A 2008-05-20 2009-05-20 Nuevo ácido l-glurámico marcado con [f-18] y derivados de l-glutamina marcada con [f-18] (ii), su uso y procedimientos para su preparación UY31836A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08075508A EP2123619A1 (de) 2008-05-20 2008-05-20 Neue [F-18]-Markierte L-Glutaminsäure-und L-Glutaminderivate (II), ihre Verwendung sowie Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
UY31836A true UY31836A (es) 2010-01-05

Family

ID=39767162

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001031836A UY31836A (es) 2008-05-20 2009-05-20 Nuevo ácido l-glurámico marcado con [f-18] y derivados de l-glutamina marcada con [f-18] (ii), su uso y procedimientos para su preparación

Country Status (13)

Country Link
US (1) US20110104057A1 (es)
EP (2) EP2123619A1 (es)
JP (1) JP2011522799A (es)
KR (1) KR20110009166A (es)
CN (1) CN102036936A (es)
AR (1) AR073843A1 (es)
CA (1) CA2723459A1 (es)
CL (1) CL2009001238A1 (es)
PA (1) PA8827201A1 (es)
PE (1) PE20100140A1 (es)
TW (1) TW201008586A (es)
UY (1) UY31836A (es)
WO (1) WO2009141079A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ576582A (en) * 2006-11-01 2011-12-22 Bayer Schering Pharma Ag [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation
US20120189546A1 (en) * 2009-07-11 2012-07-26 Bayer Pharma Aktiengesellschaft Radiolabelling Method Using Cycloalkyl Groups
MX2012005733A (es) * 2009-11-17 2013-01-22 Bayer Ip Gmbh Metodo de produccion de derivados de acido glutamico marcados con f-18.
EP2520556A1 (en) 2011-05-03 2012-11-07 Bayer Pharma Aktiengesellschaft Radiolabeled amino acids for diagnostic imaging
CN103333079B (zh) * 2013-07-03 2016-08-17 广东回旋医药科技股份有限公司 亚氨基酸类pet显像剂及其制备方法与应用
CN106631863B (zh) * 2016-09-06 2018-08-17 中山大学附属第一医院 亚谷氨酸类pet显像剂的放射合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1461184A (fr) 1964-12-23 1966-01-07 Takeda Chemical Industries Ltd Procédé de préparation d'isoxazolidones substituées en position 5
GB1474377A (en) 1973-09-11 1977-05-25 Beecham Group Ltd Naphthalene derivatives
EP1049696A1 (en) 1998-01-21 2000-11-08 MERCK SHARP & DOHME LTD. Triazolo-pyridazine derivatives as ligands for gaba receptors
AU2001278945A1 (en) * 2000-08-10 2002-02-25 Eli Lilly And Company 4-substituted d-glutamic acid derivatives for use as antibiotic
JP2006516547A (ja) * 2002-08-02 2006-07-06 マリンクロッド・インコーポレイテッド 放射性標識アミノ酸類似体、それらの製造および使用
NZ576582A (en) * 2006-11-01 2011-12-22 Bayer Schering Pharma Ag [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation

Also Published As

Publication number Publication date
AR073843A1 (es) 2010-12-09
WO2009141079A8 (de) 2010-11-18
KR20110009166A (ko) 2011-01-27
PE20100140A1 (es) 2010-03-21
CA2723459A1 (en) 2009-11-26
CL2009001238A1 (es) 2010-06-04
JP2011522799A (ja) 2011-08-04
EP2280915A1 (de) 2011-02-09
US20110104057A1 (en) 2011-05-05
PA8827201A1 (es) 2009-12-16
EP2123619A1 (de) 2009-11-25
CN102036936A (zh) 2011-04-27
WO2009141079A1 (de) 2009-11-26
TW201008586A (en) 2010-03-01

Similar Documents

Publication Publication Date Title
UY31835A (es) Nuevos derivados de ácido l-glutámico y l-glutamina marcados con [f-18] (i), su uso y procedimiento para su preparación
CU20090072A7 (es) Ácido l-glutámico marcado con [f-18], l-glutamina marcada con [f-18], sus derivados y su uso, así como procedimientos para su preparación
CR11776A (es) Inhibidores de bace
ECSP12011581A (es) Inhibidores de bace
CR11623A (es) Compuestos
CO6491116A2 (es) Derivados de 5-fluoropirimidinona
CO6321282A2 (es) Derivados de piperidinilindol como inhibidores de aldosterona sintasa
CR20120158A (es) Compuestos de diòxido de iminotiadiazina como inhibidores de bace, composiciones y su uso.
NI201200020A (es) Derivados de n1 - sulfonil - 5 - fluoropirimidinona
AR075291A1 (es) Proceso para la preparcion de derivados de l-alanina protegidos
UY32013A (es) Nuevo procedimiento de síntesis de la agomelatina
ECSP099565A (es) Compuesto de 2-amino pirimidina
UY31836A (es) Nuevo ácido l-glurámico marcado con [f-18] y derivados de l-glutamina marcada con [f-18] (ii), su uso y procedimientos para su preparación
ECSP12011653A (es) Derivados de n1-acil-5-fluoropirimidinona
ECSP12011651A (es) Derivados de 5-fluoro-2-oxopirimidina-1(2h)-carboxilato
CR11824A (es) Derivados heterocíclicos de la urea y sus métodos de empleo
UY31905A (es) Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones.
CO6351723A2 (es) Derivados de pirazolo-[5,1-b]-oxazol como antagonistas de crf1
CO6751286A2 (es) Síntesis de derivados de 2-carboxamida-cicloamino-urea
DOP2010000155A (es) Derivados de pirazol como inhibidores de 5-lo
ECSP088933A (es) Métodos para preparar derivados de ácido glutámico y sus intermedios
ECSP13013080A (es) Derivados de pirazol útiles como inhibidores de aldosterona sintasa
UY32349A (es) Derivados de biaril-bencil-amina
CU20100228A7 (es) Nuevos derivados de ácido l-glutámico y l-glutamina marcados con [f-18] (1), su uso y procedimiento para su preparación
DOP2009000098A (es) Ácido l-glutamico marcado con [f-18], l-glutamina marcada con [f-18], sus derivados y su uso, así como procedimientos para su preparación

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20181026